|
시장보고서
상품코드
2055054
계산 병리학 시장 : 제품 유형별, 도입 형태별, 유형별, 기술(머신러닝)별, 용도별, 워크플로우 단계별, 최종사용자별, 영상 유형별, 지역별Computational Pathology Market, By Product Type, By Deployment Mode, By Type, By Technology Machine Learning, By Application, By Workflow Stage, By End User, By Image Type, By Geography |
||||||
계산 병리학 시장은 2026년에 7억 9,800만 달러로 추정되며, 2033년까지 14억 8,710만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 9.3%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 7억 9,800만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.30% | 2033년 시장 규모 예측 : | 14억 8,710만 달러 |
세계 계산 병리학 시장은 인공지능, 디지털 이미징 및 기존 병리학 실무가 융합된 혁신적인 분야로, 의료진이 조직 검체를 진단하고 분석하는 방식을 근본적으로 변화시키고 있습니다. 이 혁신적인 분야에서는 첨단 머신러닝 알고리즘, 딥러닝 신경망, 그리고 고해상도 전체 슬라이드 이미징 기술을 활용하여 병리 진단의 정확성, 효율성 및 일관성을 향상시키고 있습니다. 계산 병리학 시스템은 기존의 유리 슬라이드를 고해상도 디지털 이미지로 변환하여, 병리 전문의가 전례 없는 정밀도로 원격 상담, 정량 분석 및 패턴 인식을 수행할 수 있도록 합니다.
이 기술은 암 진단, 신약 개발, 바이오마커 규명, 예측 분석 등 다양한 응용 분야를 아우르며, 현대 의료 인프라에서 없어서는 안 될 도구로 자리매김하고 있습니다. 전 세계 의료 시스템이 환자 수 증가, 자격을 갖춘 병리 전문의 부족, 그리고 맞춤형 의료에 대한 수요 증가라는 과제에 직면한 가운데, 계산 병리학은 기존 진단 기법과 차세대 의료 서비스 사이의 격차를 해소할 중요한 해결책으로 부상하고 있습니다. 인공지능과 병리 워크플로우의 통합은 진단까지 걸리는 시간을 단축할 뿐만 아니라, 인적 오류를 줄이고, 서로 다른 검사실 간의 소견 해석을 표준화하며, 종양학, 면역학 및 기타 다양한 의료 전문 분야에서 근거에 기반한 임상적 의사결정을 뒷받침하는 종합적인 데이터 분석을 가능하게 합니다.
시장 역학
세계 계산 병리학 시장은 전 세계 의료 기관에서의 도입을 전반적으로 가속화하는 몇 가지 강력한 촉진요인에 의해 주도되고 있습니다. 주요 성장 동력은 전 세계적으로, 특히 개발도상 지역에서 자격을 갖춘 병리 전문의가 심각하게 부족하기 때문이며, 이로 인해 기존 인력의 역량을 강화하고 진단 처리 능력을 향상시킬 수 있는 AI 기반 진단 솔루션에 대한 시급한 수요가 발생하고 있습니다. 전 세계 암 발병률 증가와 더불어 조기 발견 및 맞춤형 치료에 대한 인식이 높아지면서, 종양의 특성을 보다 정확하게 평가하고 예후에 대한 인사이트를 제공할 수 있는 첨단 병리 분석 도구에 대한 수요가 크게 증가하고 있습니다.
정밀의료와 동반 진단에 대한 관심이 높아지고 있는 점도 시장 확대를 더욱 가속화하고 있습니다. 제약 회사와 연구 기관은 바이오마커를 규명하고 신약을 개발하는 과정에서 고도의 분석 도구가 필요하기 때문입니다. 그러나 이 시장은 디지털 병리학 인프라에 대한 높은 초기 투자 비용, 지역마다 다른 복잡한 규제 승인 절차, 그리고 기존의 현미경 기반 업무 흐름에 익숙한 기존 병리학자들 사이에서 나타나는 변화에 대한 강한 거부감 등 큰 제약에 직면해 있습니다. 데이터 보안에 대한 우려, 특히 환자의 개인정보 보호 및 HIPAA(의료보험 이동성 및 책임에 관한 법률) 준수 관련 우려는 보급을 위한 또 다른 과제로 대두되고 있습니다. 게다가 표준화된 프로토콜의 부재와 서로 다른 계산 병리학 플랫폼 간의 상호 운용성 문제는 의료 기관의 도입에 걸림돌이 되고 있습니다.
이러한 과제가 있음에도 불구하고, 인공지능 및 머신러닝 알고리즘의 급속한 기술 발전, 의료 디지털화 노력의 확대, 디지털 헬스 기술에 대한 벤처 캐피털 투자 증가에 힘입어 시장에는 막대한 기회가 존재합니다. 최근 전 세계적인 보건 문제로 인해 가속화된 원격의료 분야의 확대는 원격 병리 상담 및 분산형 진단 서비스의 새로운 길을 열어주고 있으며, 한편 아시아태평양과 라틴아메리카의 신흥 시장은 계산 병리학의 도입에 있어 아직 개척되지 않은 막대한 잠재력을 지니고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 계산병리학 시장의 주요 기업 프로파일을 작성했습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 계산 병리학 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 계산 병리학 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 계산 병리학 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 계산 병리학 시장 : 도입 모드별, 2021년-2033년
제6장 세계의 계산 병리학 시장 : 유형별, 2021년-2033년
제7장 세계의 계산 병리학 시장 : 기술별, 2021년-2033년
제8장 세계의 계산 병리학 시장 : 용도별, 2021년-2033년
제9장 세계의 계산 병리학 시장 : 워크플로우 단계별, 2021년-2033년
제10장 세계의 계산 병리학 시장 : 최종사용자별, 2021년-2033년
제11장 세계의 계산 병리학 시장 : 영상 유형별, 2021년-2033년
제12장 세계의 계산 병리학 시장 : 지역별, 2021년-2033년
제13장 경쟁 구도
제14장 애널리스트의 제안
제15장 참고 문헌 및 조사 방법
LSH 26.06.22Computational Pathology Market is estimated to be valued at USD 798.0 Mn in 2026 and is expected to reach USD 1,487.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 798 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.30% | 2033 Value Projection: | USD 1,487.1 Mn |
The global computational pathology market represents a transformative convergence of artificial intelligence, digital imaging, and traditional pathology practices, fundamentally reshaping how medical professionals diagnose and analyze tissue samples. This innovative field leverages advanced machine learning algorithms, deep learning neural networks, and high-resolution whole slide imaging technologies to enhance the accuracy, efficiency, and consistency of pathological diagnoses. Computational pathology systems digitize conventional glass slides into high-resolution digital images, enabling pathologists to perform remote consultations, quantitative analysis, and pattern recognition with unprecedented precision.
The technology encompasses various applications including cancer diagnosis, drug discovery, biomarker identification, and predictive analytics, making it an indispensable tool in modern healthcare infrastructure. As healthcare systems worldwide grapple with increasing patient volumes, shortage of qualified pathologists, and growing demand for personalized medicine, computational pathology emerges as a critical solution that bridges the gap between traditional diagnostic methods and next-generation healthcare delivery. The integration of artificial intelligence with pathology workflows not only accelerates diagnostic timelines but also reduces human error, standardizes interpretations across different laboratories, and enables comprehensive data analysis that supports evidence-based clinical decision-making in oncology, immunology, and various other medical specialties.
Market Dynamics
The global computational pathology market is propelled by several compelling drivers that collectively accelerate its adoption across healthcare institutions worldwide. The primary growth catalyst stems from the acute shortage of qualified pathologists globally, particularly in developing regions, creating an urgent need for AI-powered diagnostic solutions that can augment existing workforce capabilities and improve diagnostic throughput. Rising cancer incidence rates worldwide, coupled with increasing awareness about early detection and personalized treatment approaches, significantly drives demand for advanced pathological analysis tools that can provide more precise tumor characterization and prognostic insights.
The growing emphasis on precision medicine and companion diagnostics further accelerates the market expansion, as pharmaceutical companies and research institutions require sophisticated analytical tools for biomarker identification and drug development processes. However, the market faces substantial restraints including high initial investment costs for digital pathology infrastructure, complex regulatory approval processes across different geographical regions, and significant resistance to change among traditional pathologists who are accustomed to conventional microscopy-based workflows. Data security concerns, particularly regarding patient privacy and HIPAA compliance, pose additional challenges for widespread adoption. Furthermore, the lack of standardized protocols and interoperability issues between different computational pathology platforms create implementation barriers for healthcare institutions.
Despite these challenges, the market presents tremendous opportunities driven by rapid technological advancements in artificial intelligence and machine learning algorithms, increasing healthcare digitization initiatives, and growing venture capital investments in digital health technologies. The expanding telemedicine sector, accelerated by recent global health challenges, creates new avenues for remote pathology consultations and distributed diagnostic services, while emerging markets in Asia Pacific and Latin America offer substantial untapped potential for computational pathology adoption.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global computational pathology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Roche Diagnostics, Koninklijke Philips N.V., Leica Biosystems, 3DHISTECH Ltd, Hamamatsu Photonics K.K., Indica Labs Inc., Proscia Inc., Paige AI, Ibex Medical Analytics Ltd, Aiforia Technologies Plc, Mindpeak GmbH, Tribun Health, Aiosyn B.V., Visiopharm A/S, and Nikon Instruments Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global computational pathology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global computational pathology market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Software
- Hardware
- Services
- Deployment Mode Insights (Revenue, USD Mn, 2021 - 2033)
- On-Premise
- Cloud Based
- Type Insights (Revenue, USD Mn, 2021 - 2033)
- Standalone Computational Pathology Software
- Integrated Digital Pathology Platforms
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Machine Learning (Non-Deep Learning)
- Deep Learning and Neural Networks
- Computer Vision and Image Processing
- Predictive and Prescriptive Analytics
- Cloud Computing and Edge Computing
- Big Data and High-Performance Computing (HPC)
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Disease Diagnosis
- Drug Discovery and Development
- Clinical Workflow Optimization
- Quantitative Image Analysis
- Predictive and Prognostic Modeling
- Biomarker Quantification
- Workflow Stage Insights (Revenue, USD Mn, 2021 - 2033)
- Pre-Analytical
- Analytical
- Post-Analytical
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
- Image Type Insights (Revenue, USD Mn, 2021 - 2033)
- Whole Slide Images
- Microscopy Images
- Radiology-Pathology Integrated Images
- Multi-Omics Integrated Images
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Roche Diagnostics
- Koninklijke Philips N.V.
- Leica Biosystems
- 3DHISTECH Ltd
- Hamamatsu Photonics K.K.
- Indica Labs Inc.
- Proscia Inc.
- Paige AI
- Ibex Medical Analytics Ltd
- Aiforia Technologies Plc
- Mindpeak GmbH
- Tribun Health
- Aiosyn B.V.
- Visiopharm A/S
- Nikon Instruments Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Computational Pathology Market, By Product Type
- Global Computational Pathology Market, By Deployment Mode
- Global Computational Pathology Market, By Type
- Global Computational Pathology Market, By Technology
- Global Computational Pathology Market, By Application
- Global Computational Pathology Market, By Workflow Stage
- Global Computational Pathology Market, By End User
- Global Computational Pathology Market, By Image Type
- Global Computational Pathology Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Computational Pathology Market, By Product Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Computational Pathology Market, By Deployment Mode, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Cloud Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Computational Pathology Market, By Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Standalone Computational Pathology Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Integrated Digital Pathology Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Computational Pathology Market, By Technology, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Machine Learning (Non-Deep Learning)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Deep Learning and Neural Networks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Computer Vision and Image Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Predictive and Prescriptive Analytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Cloud Computing and Edge Computing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Big Data and High-Performance Computing (HPC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Computational Pathology Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Disease Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Clinical Workflow Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Quantitative Image Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Predictive and Prognostic Modeling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Biomarker Quantification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
9. Global Computational Pathology Market, By Workflow Stage, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pre-Analytical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Analytical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Post-Analytical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
10. Global Computational Pathology Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
11. Global Computational Pathology Market, By Image Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Whole Slide Images
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Microscopy Images
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Radiology-Pathology Integrated Images
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Multi-Omics Integrated Images
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
12. Global Computational Pathology Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Image Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Image Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Image Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Image Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Image Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Image Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Leica Biosystems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 3DHISTECH Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hamamatsu Photonics K.K.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Indica Labs Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Proscia Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Paige AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ibex Medical Analytics Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aiforia Technologies Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mindpeak GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tribun Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aiosyn B.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Visiopharm A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nikon Instruments Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
